Dexmedetomidine Reduced Cytokine Release during Postpartum Bleeding-Induced Multiple Organ Dysfunction Syndrome in Rats
Dexmedetomidine (DEX) is an α2-adrenergic agonist. It decreases the levels of norepinephrine release, resulting in a reduction of postsynaptic adrenergic activity. In the present study, the effects of DEX on postpartum bleeding-induced multiple organ dysfunction syndrome (BMODS) were studied in rats...
Main Authors: | Liu Xianbao, Zhan Hong, Zeng Xu, Zhang Chunfang, Chen Dunjin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/627831 |
Similar Items
-
Role of dexmedetomidine in IL-4 and IFN-γ expression in rats with multiple organ dysfunction syndrome induced by postpartum bleeding
by: Chunfang Zhang, et al.
Published: (2015-12-01) -
The PBDE-209 Exposure during Pregnancy and Lactation Impairs Immune Function in Rats
by: Xianbao Liu, et al.
Published: (2012-01-01) -
Cytokine release syndrome
by: Alexander Shimabukuro-Vornhagen, et al.
Published: (2018-06-01) -
Cytokine release syndrome
by: Esra Yildizhan, et al.
Published: (2018-12-01) -
Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy
by: Liu H, et al.
Published: (2019-10-01)